Trial Profile
A study evaluating the efficacy and safety of Dihydroartemisinine-piperaquine for the treatment of uncomplicated plasmodium falciparum malaria, and chloroquine for plasmodium vivax in Homalin (Sagaing Division), Lashio (Shan State) and Bokepyin (Tanintharyi Division)
Status:
Recruiting
Phase of Trial:
Phase III/IV
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Dihydroartemisinin/piperaquine (Primary) ; Chloroquine
- Indications Falciparum malaria; Vivax malaria
- Focus Therapeutic Use
- 21 Mar 2014 New trial record